|
Exhibit
10.1
Execution
Copy
AMENDED AND RESTATED
STOCK AND ASSET PURCHASE AGREEMENT
Dated as of March 17,
2005
Among
BIOTAGE AB
and
ARGONAUT TECHNOLOGIES,
INC.
TABLE OF
CONTENTS
|
|
|
|
|
|
|
| |
|
|
|
|
|
Page
|
|
ARTICLE I DEFINITIONS
|
|
2 |
|
|
|
|
| |
|
1.1 |
|
Defined
Terms. |
|
2 |
| |
|
1.2 |
|
Other
Defined Terms |
|
8 |
| |
|
1.3 |
|
Rules of
Construction |
|
9 |
|
|
|
ARTICLE II PURCHASE AND SALE OF THE
TRANSFERRED SUBSIDIARIES AND THE TRANSFERRED ASSETS
|
|
10 |
|
|
|
|
| |
|
2.1 |
|
Sale of
the Transferred Subsidiaries |
|
10 |
| |
|
2.2 |
|
Purchase
and Sale of Transferred Assets |
|
10 |
| |
|
2.3 |
|
Assumption of Liabilities |
|
14 |
| |
|
2.4 |
|
Transfer
of Purchased Assets and Assumed Liabilities |
|
16 |
| |
|
2.5 |
|
Procedures for Assets Not Transferable |
|
16 |
| |
|
2.6 |
|
Payments
Post-Closing |
|
17 |
|
|
|
ARTICLE III PURCHASE PRICE AND
ADJUSTMENTS
|
|
18 |
|
|
|
|
| |
|
3.1 |
|
Purchase
Price |
|
18 |
| |
|
3.2 |
|
Payment
of Purchase Price and Estimated Purchase Price
Adjustment |
|
18 |
| |
|
3.3 |
|
Closing
Date Net Working Capital Statement; Schedule of Cash and Cash
Equivalents; and Actual Adjustment Amount. |
|
19 |
| |
|
3.4 |
|
Allocation of Purchase Price |
|
21 |
|
|
|
ARTICLE IV REPRESENTATIONS AND
WARRANTIES
|
|
22 |
|
|
|
|
| |
|
4.1 |
|
Representations and Warranties of the Company |
|
22 |
| |
|
4.2 |
|
Representations and Warranties of the Buyer |
|
39 |
|
|
|
ARTICLE V COVENANTS
|
|
41 |
|
|
|
|
| |
|
5.1 |
|
Access;
Information and Records; Confidentiality |
|
41 |
| |
|
5.2 |
|
Conduct
of the Business Prior to the Closing Date |
|
42 |
| |
|
5.3 |
|
Acquisition Proposals. |
|
46 |
| |
|
5.4 |
|
Non-Solicitation |
|
48 |
| |
|
5.5 |
|
Non-Competition |
|
48 |
| |
|
5.6 |
|
Further
Actions; Best Efforts. |
|
49 |
| |
|
5.7 |
|
Stockholder Approval; Preparation of Proxy
Statement. |
|
49 |
| |
|
5.8 |
|
Public
Announcements |
|
50 |
| |
|
5.9 |
|
Company
Employee Benefits. |
|
50 |
| |
|
5.10 |
|
Insurance |
|
52 |
| |
|
5.11 |
|
Reorganization |
|
53 |
| |
|
5.12 |
|
Certain
Notices |
|
53 |
|
|
|
|
|
|
|
| |
|
5.13 |
|
Certain
Intellectual Property Covenants. |
|
53 |
| |
|
5.14 |
|
WARN |
|
54 |
| |
|
5.15 |
|
Intercompany Accounts |
|
54 |
| |
|
5.16 |
|
Confidentiality |
|
54 |
| |
|
5.17 |
|
Successors |
|
54 |
|
|
|
ARTICLE VI TAX MATTERS
|
|
55 |
|
|
|
|
| |
|
6.1 |
|
Control
of Tax Audits |
|
55 |
| |
|
6.2 |
|
Tax
Returns |
|
55 |
| |
|
6.3 |
|
Cooperation; Other Tax Matters |
|
56 |
| |
|
6.4 |
|
Transfer
Taxes |
|
56 |
| |
|
6.5 |
|
Straddle
Periods |
|
56 |
| |
|
6.6 |
|
Proration
of Taxes |
|
56 |
| |
|
6.7 |
|
Section
338 Elections |
|
57 |
| |
|
6.8 |
|
Tax
Refunds |
|
57 |
|
|
|
ARTICLE VII Closing
|
|
57 |
|
|
|
|
| |
|
7.1 |
|
Closing
Date |
|
57 |
| |
|
7.2 |
|
Deliveries by the Buyer |
|
57 |
| |
|
7.3 |
|
Deliveries by the Company |
|
58 |
| |
|
7.4 |
|
Actions
at Closing Meeting |
|
59 |
|
|
|
ARTICLE VIII CONDITIONS
PRECEDENT
|
|
59 |
|
|
|
|
| |
|
8.1 |
|
Conditions Precedent to Obligations of Parties |
|
59 |
| |
|
8.2 |
|
Conditions to Obligations of the Buyer |
|
60 |
| |
|
8.3 |
|
Conditions to the Obligations of the Company |
|
61 |
|
|
|
ARTICLE IX TERMINATION
|
|
61 |
|
|
|
|
| |
|
9.1 |
|
Termination |
|
61 |
| |
|
9.2 |
|
Effect of
Termination |
|
63 |
|
|
|
ARTICLE X Indemnification
|
|
64 |
|
|
|
|
| |
|
10.1 |
|
Indemnification |
|
64 |
| |
|
10.2 |
|
Limitations on Indemnity Payments |
|
66 |
| |
|
10.3 |
|
Notice of
Indemnity Claims |
|
67 |
| |
|
10.4 |
|
Indemnification Procedures |
|
67 |
| |
|
10.5 |
|
Settlement of Indemnity Claims |
|
68 |
| |
|
10.6 |
|
Survival |
|
69 |
| |
|
10.7 |
|
Treatment
of Indemnification Payments |
|
69 |
| |
|
10.8 |
|
Remedies
Exclusive |
|
69 |
|
|
|
|
|
|
|
|
|
|
ARTICLE XI MISCELLANEOUS
|
|
69 |
|
|
|
|
| |
|
11.1 |
|
Notices |
|
69 |
| |
|
11.2 |
|
Counterparts; Facsimile Signature |
|
70 |
| |
|
11.3 |
|
Bulk
Sales |
|
71 |
| |
|
11.4 |
|
Further
Assurances |
|
71 |
| |
|
11.5 |
|
Entire
Agreement |
|
71 |
| |
|
11.6 |
|
No
Third-Party Beneficiaries |
|
71 |
| |
|
11.7 |
|
Assignment |
|
71 |
| |
|
11.8 |
|
Amendment
and Modification; Waiver |
|
71 |
| |
|
11.9 |
|
Enforcement; Jurisdiction |
|
72 |
| |
|
11.10 |
|
Waiver of
Jury Trial |
|
72 |
| |
|
11.11 |
|
Costs and
Expenses |
|
72 |
| |
|
11.12 |
|
Setoff |
|
72 |
| |
|
11.13 |
|
Casualty
Losses |
|
73 |
| |
|
11.14 |
|
Mutual
Drafting. |
|
73 |
| |
|
11.15 |
|
Governing
Law |
|
73 |
| |
|
11.16 |
|
Disclosure Schedules. |
|
73 |
| |
|
11.17 |
|
Severability |
|
73 |
AMENDED AND RESTATED STOCK
AND ASSET PURCHASE AGREEMENT
AMENDED AND RESTATED STOCK
AND ASSET PURCHASE AGREEMENT , dated as of February 21, 2005,
as amended and restated as of March 17, 2005 (such date, the
“ Amendment Date ” and as amended this “
Agreement ”), among Biotage AB, a corporation
organized under the laws of Sweden (the “ Buyer
”) and Argonaut Technologies, Inc., a Delaware corporation
(the “ Company ”).
RECITALS
WHEREAS , the Company,
including through its Subsidiaries, is engaged in the chemistry
consumables business, which includes the following segments: (i)
Argoresins, (ii) Solid Phase Extraction Systems, Consumables and
Services, (iii) Flash Chromatography Systems, Consumables and
Services and (iv) Quest, Trident and Nautalis Discontinued Systems,
Consumables and Services (collectively, the “ Consumables
Business ”);
WHEREAS , the Company,
including through its Subsidiaries, also is engaged in the business
of developing and manufacturing instruments and related services to
address the chemical development workflow of compound synthesis for
the pharmaceutical and specialty chemical industries which is
conducted through the Company’s Advantage Series
2410/3400/4100, Endeavor and, Atlantis, Surveyor and Firstmate
product lines (the “ Process Business
”);
WHEREAS , upon the
terms and conditions set forth herein, the Buyer, through one or
more of its direct or indirect Subsidiaries, desires to purchase,
and the Company desires to sell or cause to be sold (the “
Acquisition ”) to the Buyer and/or one or more of
Buyer’s direct or indirect Subsidiaries set forth on
Exhibit A (the “ Designated Purchasers
”): (i) all of the outstanding shares of capital stock of
Argonaut Technologies Limited, a corporation organized under the
laws of the United Kingdom (the “ Transferred
Subsidiary ”), (ii) certain of the assets and liabilities
of the Company related to the Consumables Business as described
herein and (iii) certain of the assets and liabilities of the
Company related to the Process Business as described herein (the
“ Transferred Process Operations ”);
WHEREAS , the Board of
Directors of the Company has, by the unanimous vote of all
directors (i) determined that the Acquisition and the transactions
contemplated by this Agreement are expedient and in the best
interests of the Company and its stockholders and (ii) declared the
advisability of this Agreement and resolved to recommend that the
Company’s stockholders approve the Acquisition and the
consummation of the transactions contemplated by this Agreement;
and
NOW, THEREFORE , in
consideration of the foregoing and the respective representations,
warranties, covenants and agreements set forth herein, and
intending to be legally bound hereby, the parties hereto agree as
follows:
ARTICLE I
DEFINITIONS
1.1 Defined Terms .
Defined terms used in this Agreement have the meanings ascribed to
them as follows:
“Accounts”
shall mean the audited balance sheets and the audited profit and
loss accounts of each of the Transferred Subsidiaries in respect of
the accounting reference period of the Transferred Subsidiaries
ended on the Accounts Date.
“ Accounts Date
” shall mean December 31, 2003.
“ Acquired
Businesses” shall mean, collectively, the Consumables
Business and the Transferred Process Operations.
“ Acquisition
Proposal ” shall mean, other than the transactions
contemplated hereby or any offer or proposal made by the Buyer or a
Subsidiary of the Buyer, any inquiry with respect to, or a proposal
or offer for a tender offer or exchange offer, merger,
reorganization, share exchange, consolidation or other business
combination involving, the Company and its Subsidiaries or any
proposal or offer to acquire in any manner an equity interest
representing a 10% or greater economic or voting interest in the
Company, or the assets, securities or ownership interests of or in
the Company or any of its Subsidiaries representing 10% or more of
the consolidated assets of the Company and its Subsidiaries, other
than (i) a proposal with respect to a purchase of the
Company’s property located at Tir-Y-Berth Industrial Estate,
New Road, Hengoed, Wales and (ii) after any termination hereof, any
proposal for a bona fide equity financing transaction made after
such termination by a Person who has not made an Acquisition
Proposal prior to such termination and which represents a 30% or
less economic and voting interest in the Company.
“ Affiliate
” shall mean, with respect to any Person, any other Person
that directly or indirectly, through one or more intermediaries,
controls, is controlled by, or is under common control with, such
Person. When used in this Agreement, “control”
(including, with its correlative meanings, the terms
“controlling”, “controlled by” and
“under common control with”) shall mean the possession,
direct or indirect, of the power to direct or cause the direction
of the management and policies of a Person, whether through the
ownership of voting securities, by Contract or
otherwise.
“ Books and
Records ” shall mean originals or true copies of all
agreements, documents, books, records and files, of the Company and
its Subsidiaries, including records and files stored on computer
disks or tapes or any other storage medium prepared, used or held
for use principally in connection with the conduct or operation of
the Consumables Business or the Transferred Process Operations,
including the certificates of incorporation, check books, common
seals and all statutory and minute books (which for the purposes of
Article VII shall be written up to the date of Closing), and
all unused share certificate forms, in each case of the Transferred
Subsidiaries.
2
“ Business Day
” shall mean any day other than (i) a Saturday or Sunday or
(ii) a day on which banks in San Francisco, California, New York,
New York or Stockholm, Sweden are required or authorized by law,
executive order or governmental decree to be closed.
“ Buyer Disclosure
Schedule ” shall mean the Buyer’s disclosure
schedule delivered by the Buyer to the Company prior to the
execution of this Agreement.
“ Code ”
shall mean the Internal Revenue Code of 1986, as
amended.
“ Company Disclosure
Schedule ” shall mean the Company’s disclosure
schedule delivered by the Company to the Buyer within five (5)
Business Days after the Amendment Date, which may not, without the
Buyer’s prior written consent, include any exception item
that was not disclosed in writing to the Buyer prior to entry into
this Agreement as part of the due diligence process
conducted.
“ Company
Employees ” shall mean the Transferred Subsidiary
Employees, Process Business Employees and US Consumables Employees,
collectively, who are, immediately prior to the Closing, employed
with the Company or any of its Affiliates.
“ Confidentiality
Agreement ” shall mean the Confidentiality Agreement
dated January 7, 2004, as amended between the Company and the
Buyer.
“ Consumables
Business Employee ” shall mean any current or former
employee, director, officer, independent contractor or consultant
of the Consumables Business, and for purposes of completeness,
shall include the Transferred Subsidiary Employees.
“ Contracts
” shall mean all written and oral contracts, agreements,
leases, subleases, licenses, purchase orders, instruments of
indebtedness, mortgages, deeds of trust, guarantees and any other
binding contractual arrangements related principally to the
operation of the Consumables Business or the Process Business or to
which the Transferred Assets are subject. “ DGCL
” shall mean the Delaware General Corporation Law, as the
same may be amended from time to time.
“ dollars
” or “ $ ” shall mean United States
dollars.
“ Environmental
Laws ” shall mean all applicable Laws or Orders relating
to (i) pollution, contamination, restoration or protection of the
environment, health or safety or natural resources, (ii) the
handling, use, presence, disposal, release or threatened release of
any Hazardous Substance or (iii) noise, odor, wetlands, pollution,
contamination, waste or injury or threat of injury to Persons or
property.
“ ERISA ”
shall mean the Employee Retirement Income Security Act of 1974, as
amended, and the rules and regulations promulgated
thereunder.
“ Exchange Act
” or “ 1934 Act ” shall mean the
Securities Exchange Act of 1934, as amended, and the rules and
regulations promulgated thereunder.
“ GAAP ”
shall mean United States generally accepted accounting
principles.
3
“ Governmental
Authority ” shall mean any federal, state, municipal,
foreign or other governmental body, department, commission, board,
bureau, agency, court or instrumentality, domestic or foreign, or
other entity exercising any executive, legislative, judicial,
quasi-judicial, regulatory or administrative function of
government.
“ Hazardous
Substance ” shall mean any substance that is (i) listed,
classified or regulated pursuant to any Environmental Law, (ii) any
petroleum or petroleum product or by-product, asbestos-containing
material, lead-containing paint or plumbing, polychlorinated
biphenyls, radioactive materials or radon or (iii) any other
substance which may be the subject of regulatory action by any
Governmental Authority pursuant to any Environmental
Law.
“ Intellectual
Property ” shall mean collectively, on a worldwide basis,
all of the following types of intangible assets: (i) all inventions
(whether patentable or unpatentable and whether or not reduced to
practice), all improvements thereto, and all patents, patent
applications, and patent disclosures, together with all
reissuances, continuations, continuations-in-part, revisions,
extensions, and re-examinations thereof, (ii) all trademarks,
service marks, trade dress, logos, domain names, URLs, trade names,
brand names, model names, corporate names and other source
indicators, including all goodwill associated therewith, and all
applications, registrations, and renewals in connection therewith,
(iii) all copyrights (whether registered or unregistered), and all
applications, registrations and renewals in connection therewith,
(iv) all mask works and all applications, registrations, and
renewals in connection therewith, (v) all trade secrets and
confidential information (including confidential ideas, research
and development, know-how, formulas, compositions, manufacturing
and production processes and techniques, technical data, designs,
drawings, specifications, customer and supplier lists, pricing and
cost information, and marketing plans and proposals), (vi) all
computer software (including data and related documentation and
including software installed on hard disk drives and any related
source codes), (vii) all joint or partial interests in any of the
foregoing and (viii) all rights to pursue, recover and retain
damages, costs and attorneys’ fees for past, present and
future infringement or misappropriations of the
foregoing.
“ Inventory
” means all inventory and all raw materials, work-in-process,
finished products, supplies, accessories, packaging materials,
goods or parts, in each case whether or not in transit on the
Closing Date, that are used or held for use principally in the
conduct or operation of the Consumables Business or the Process
Business. For the avoidance of doubt, “Inventory” shall
include all discontinued products, service and spare parts
inventory, including finished goods inventory and any and all stock
that may be represented in the gross inventory values prior to
reserves, including with respect to the Quest, Trident and Nautalis
Discontinued Systems, Consumables and Services line of the
Consumables Business.
“ Knowledge of the
Buyer ” shall mean, with respect to any matter in
question, the knowledge, after reasonable inquiry, of those
individuals listed in Section 1.1(i) of the Buyer Disclosure
Schedule.
“ Knowledge of the
Company ” shall mean, with respect to any matter in
question, the knowledge, after reasonable inquiry, of individuals
listed in Section 1.1(i) of the Company Disclosure
Schedule.
4
“ Law ”
shall mean any federal, state, local or foreign law, statute,
common law, rule, regulation, code, directive, ordinance or other
requirement of general application of any Governmental Authority,
including Environmental Laws.
“ Liabilities
” means any direct or indirect liability, indebtedness,
claim, loss, damage, deficiency, obligation or responsibility,
fixed or unfixed, choate or inchoate, liquidated or unliquidated,
secured or unsecured, accrued, absolute, known or unknown,
contingent or otherwise.
“ Licenses and
Permits ” shall mean all licenses, permits, concessions,
exemptions, consents, franchises, certificates, variances,
approvals and other authorizations that are required by
Governmental Authorities or otherwise under any applicable Law to
conduct each of the Consumables Business and the Transferred
Process Operations as they are presently conducted or to own or use
the Transferred Assets. “ Lien ” shall mean any
lien, claim, charge, option, mortgage, pledge or security interest,
rights of first refusal or rights of first offer, encumbrance
(including leases, easements, licenses, zoning ordinances,
covenants, conditions, restrictions and rights-of-way) or other
similar right affecting real or personal property, in each case,
whether arising by contract, operation of law or
otherwise.
“ Material Adverse
Effect ” or “ Material Adverse Change
” shall mean any event, change, circumstance or effect that
is or would reasonably be expected to be materially adverse to the
condition (financial or otherwise), properties, assets (including
intangible assets), liabilities, businesses or results of
operations of the Acquired Businesses or to have a material adverse
effect on the ability of the Company to consummate the transactions
contemplated hereunder on a timely basis; provided ,
however , that a “Material Adverse Effect” shall
not include (i) changes, effects and circumstances resulting from
(a) factors generally affecting the life sciences industry or (b)
changes in general economic, regulatory or political conditions,
including changes in the United States or worldwide capital
markets; (ii) the loss of Company Employees or customers having a
relationship with the Consumables Business or the Transferred
Process Operations as a result of the announcement or pendency of
the Acquisition, this Agreement or the transactions contemplated
hereby, (iii) compliance by the Company with its express
obligations pursuant to the terms and conditions of this Agreement;
or (iv) any change in GAAP or applicable laws, rules or regulations
that occurs or becomes effective after the date of this Agreement;
provided , that in the case of any event, change,
circumstance or effect referred to in clause (i) above, such event,
change, circumstance or effect does not have a materially
disproportionate effect on the Acquired Businesses relative to
other participants in the life sciences industry.
“ Order ”
shall mean any order, writ, injunction, judgment, decree or ruling
entered, issued, made or rendered by any court, administrative
agency, arbitration tribunal or other Governmental Authority of
competent jurisdiction.
“ Permitted
Liens ” shall mean (i) mechanics’, carriers’,
workers’ or repairmen’s Liens arising in the ordinary
course of business and securing payments or obligations that are
not delinquent, (ii) Liens for Taxes, assessments and other similar
governmental charges which are not due and payable and (iii) Liens
that arise under zoning, land use and other similar Laws and other
imperfections of title or encumbrances, if any, which do not
materially affect the marketability of the property subject thereto
and do not materially impair the use of the property subject
thereto as used as of the date hereof.
5
“ Person ”
shall mean any individual, corporation, partnership, firm, limited
liability company, joint venture, association, joint stock company,
trust, unincorporated organization, Governmental Authority or other
entity.
“ Post-Closing Tax
Period ” shall mean any taxable period beginning after
the Closing Date and, with respect to any Straddle Period, the
portion of such Straddle Period beginning after the Closing
Date.
“ Pre-Closing Tax
Period ” shall mean any taxable period ending on or
before the Closing Date and, with respect to any Straddle Period,
the portion of such Straddle Period ending on the Closing
Date.
“ Previous
Accounts” shall mean the audited balance sheets of the
Transferred Subsidiaries as of the end of each of the two
accounting reference periods immediately preceding the period ended
on the Accounts Date and the audited profit and loss accounts of
the Transferred Subsidiaries for such periods.
“ Proceeding
” shall mean any action, suit, dispute, litigation, hearing,
claim, grievance, arbitral action or other proceeding before any
Governmental Authority, at law or in equity.
“ Process Business
Employees ” shall mean the employees of the Process
Business set forth in Section 1.1(ii) of the Company
Disclosure Schedule.
“ Representative
” shall mean any attorney, accountant, financial advisor or
other authorized representative of any Person.
“ SEC ”
shall mean the United States Securities and Exchange
Commission.
“ Securities Act
” shall mean the Securities Act of 1933, as amended, and the
rules and regulations promulgated thereunder.
“ Straddle
Period ” shall mean any taxable period that begins on or
before and ends after the Closing Date.
“ Subsidiary
” and “ Subsidiaries ” when used with
respect to any Person shall mean any Person in which such Person
directly or indirectly owns 50% or more of the aggregate voting
stock. For purposes of this definition, “voting stock”
means stock or other interests that ordinarily has voting power for
the election of directors or managers.
“ Superior
Proposal ” means an Acquisition Proposal that is
reasonably capable of being consummated, taking into account all
legal, financial, regulatory, timing, and similar aspects of, and
conditions to, the proposal, the likelihood of obtaining necessary
financing and the Person making the proposal, and, which, if
consummated, would result in a transaction more favorable to the
Company’s stockholders from a financial point of view than
the transactions contemplated hereby (after giving effect to any
adjustments to the terms and provisions of this
6
Agreement proposed by Parent in response
to such Acquisition Proposal after receipt of notice of such
Acquisition Proposal as required by Section 5.3 );
provided , that for the purposes of this definition of
“Superior Proposal,” the term Acquisition Proposal
shall have the meaning assigned to such term, except that the
references to “10% or more” in the definition of
“Acquisition Proposal” shall be deemed to be references
to “a majority”.
“Tax” or
“Taxes” shall mean any taxes of any kind,
including those measured on, measured by or referred to as, income,
alternative or add-on minimum, gross receipts, escheat, capital,
capital gains, sales, use, ad valorem , franchise, profits,
license, privilege, transfer, withholding, payroll, employment,
social, excise, severance, stamp, occupation, premium, value added,
property, environmental or windfall profits taxes, customs, duties
or similar fees, assessments or charges of any kind whatsoever,
together with any interest and any penalties, additions to tax or
additional amounts (including any interest thereon) imposed by any
Governmental Authority.
“ Tax Returns
” shall mean all reports, estimates, declarations of
estimated Tax, claims for refund, information statements and
returns relating to, or required to be filed in connection with,
any Taxes, including any schedule or attachment thereto, and
including any amendment thereof.
“Target Net Working
Capital” means $7,080,000.
“ Transferred
Subsidiary Employees ” shall mean those Consumables
Business Employees whose service relationship is or was with the
Transferred Subsidiaries and that certain employee of the Process
Business employed by a Transferred Subsidiary (identified as such
in Section 1.1(ii) of the Company Disclosure
Schedule).
“ Transferred
Subsidiaries ” shall mean the Transferred Subsidiary and
each Person in which the Transferred Subsidiary owns any capital
stock or other security interest, including International Sorbent
Technology Limited, a corporation organized under the laws of
England and Wales, and Jones Chromatography U.S.A., Inc., a
Colorado corporation.
“ UK Tax
Proceeding ” shall mean any current audit or
investigation by the Inland Revenue, including any Proceedings
arising therefrom, related to intercompany transactions between the
Transferred Subsidiaries and the Company, including management
fees, intercompany charges and sales or transfers of
goods.
“UK Tax
Liability” shall mean any Pre-Closing Tax Period Taxes
for which the Transferred Subsidiaries may be liable in connection
with or as a result of the UK Tax Proceeding.
“ US Consumables
Employees ” shall mean the employees of the Consumables
Business set forth on Section 1.1(ii) of the Company
Disclosure Schedule.
7
1.2 Other Defined
Terms . The following capitalized terms are defined in this
Agreement in the Section indicated below:
|
|
|
|
Defined Term
|
|
Section
|
|
1060 Forms
|
|
3.4 |
|
Accounts Payable Statement
|
|
3.3(a) |
|
Acquired Businesses
|
|
1.1 |
|
Acquisition
|
|
Recitals |
|
Agreement
|
|
Preamble |
|
Amendment Date
|
|
Preamble |
|
Assumed Liabilities
|
|
2.3(a) |
|
Buyer
|
|
Preamble |
|
Buyer Expenses
|
|
9.2(c) |
|
Buyer Indemnified Party
|
|
10.1(a) |
|
Buyer Losses
|
|
10.1(a) |
|
Change in Company
Recommendation
|
|
5.3(b) |
|
Claim Notice
|
|
10.3 |
|
Closing
|
|
7.1 |
|
Closing Date
|
|
7.1 |
|
Closing Date Cash Statement
|
|
3.3(a) |
|
Closing Date Net Working
Capital
|
|
3.2(b) |
|
Closing Date Net Working Capital
Statement
|
|
3.3(a) |
|
Closing Statement
|
|
3.3(a) |
|
Company
|
|
Preamble |
|
Company Indemnified Party
|
|
10.1(b) |
|
Company Losses
|
|
10.1(b) |
|
Company Plans
|
|
4.1(o) |
|
Company SEC Documents
|
|
4.1(g) |
|
Company Special Meeting
|
|
5.7(b) |
|
Consents
|
|
2.5 |
|
Consumables Business
|
|
Recitals |
|
Consumables Business Balance
Sheet
|
|
2.3(a) |
|
Deficiency
|
|
3.3(d) |
|
Designated Purchasers
|
|
Recitals |
|
Escrow Funds
|
|
3.2(a) |
|
Excluded Assets
|
|
2.2(b) |
|
Excluded Liabilities
|
|
2.3(b) |
|
Financial Statements
|
|
4.1(g) |
|
Foreign Benefit Plan
|
|
4.1(o) |
|
Grace Acquisition
|
|
10.1(a) |
|
Indemnified Party
|
|
10.3 |
|
Indemnifying Party
|
|
10.3 |
|
Indemnity Claim
|
|
10.3 |
|
Independent Accounting Firm
|
|
3.3(c) |
|
Initial Closing Escrow Period
|
|
3.2(a) |
|
Inventory Count
|
|
3.3(a) |
|
Leader
|
|
5.1(b) |
|
Leased Real Property
|
|
2.2(a) |
|
Leases
|
|
4.1(i) |
|
LIBOR
|
|
3.3(e) |
8
|
|
|
|
Defined Term
|
|
Section
|
|
Noncompetition Period
|
|
5.5(a) |
|
Owned Real Property
|
|
2.2(a) |
|
Periodic Taxes
|
|
6.6 |
|
Preliminary Closing Date Net Working
Capital
|
|
3.2(b) |
|
Preliminary Closing Date Net Working
Capital Statement
|
|
3.2(b) |
|
Process Business
|
|
Recitals |
|
Process Business Balance
Sheet
|
|
4.1(g) |
|
Proxy Statement
|
|
5.7(a) |
|
Public Proposal
|
|
9.2(b) |
|
Purchase Price
|
|
3.1 |
|
Recall
|
|
4.1(x) |
|
Real Property Permits
|
|
4.1(i) |
|
Related Person
|
|
4.1(t) |
|
Reorganization
|
|
5.11 |
|
Seller Plans
|
|
5.9(d) |
|
Severance Costs
|
|
5.9(a) |
|
Stockholder Approval
|
|
4.1(c) |
|
Surplus
|
|
3.3(d) |
|
Tax Proceeding
|
|
6.1 |
|
Termination Date
|
|
9.1(b) |
|
Termination Fee
|
|
9.2(b) |
|
Third Party Claim
|
|
10.4 |
|
Transfer Costs
|
|
6.4 |
|
Transferred Assets
|
|
2.2(b) |
|
Transferred Process
Operations
|
|
Recitals |
|
Transferred Real Property
|
|
2.2(a) |
|
Transferred Shares
|
|
2.1 |
|
Transferred Subsidiary
|
|
Recitals |
|
Transferred Employees
|
|
5.9(a) |
|
Transition Team
|
|
5.1(b) |
|
Violation
|
|
4.1(d) |
|
Voting Debt
|
|
4.1(b) |
|
Wales Lease
|
|
8.2(h) |
|
WARN
|
|
4.1(p) |
1.3 Rules of
Construction . References in this Agreement to gender include
references to all genders, and references to the singular include
references to the plural and vice versa. The words
“include”, “includes” and
“including” when used in this Agreement shall be deemed
to be followed by the phrase “without limitation”.
Unless the context otherwise requires, references in this Agreement
to Articles, Sections and Schedules shall be deemed references to
Articles and Sections of, and Exhibits and Schedules to, this
Agreement. Unless the context otherwise requires, the words
“hereof”, “hereby” and “herein”
and words of similar meaning when used in this Agreement refer to
this Agreement in its entirety and not to any particular Article,
Section or provision of this Agreement. The table of contents and
headings contained in this Agreement are for reference purposes
only and shall not affect in any way the meaning or interpretation
of this Agreement. References herein to “date hereof”,
“date of this Agreement” or similar references shall
mean as of February 21, 2005.
9
ARTICLE II
PURCHASE AND SALE OF
THE TRANSFERRED SUBSIDIARIES AND THE
TRANSFERRED
ASSETS
2.1 Sale of the
Transferred Subsidiaries . Subject to the satisfaction or
waiver of the conditions set forth in this Agreement, at the
Closing and as of the Closing Date, the Company shall sell, assign,
transfer, convey and deliver to the Buyer and/or the respective
Designated Purchaser, and the Buyer shall or shall cause the
applicable Designated Purchaser to purchase and acquire, all of the
shares (the “ Transferred Shares ”) of the
Transferred Subsidiary. In connection therewith, the Company shall
deliver to the Buyer and/or the applicable Designated Purchaser
share certificates representing the Transferred Shares showing the
name of the Buyer or the applicable Designated Purchaser as the
registered holder, a transfer of all the Transferred Shares duly
executed by the Company in favor of the Buyer or the applicable
Designated Purchaser and all other documents related to the
Transferred Shares as the Buyer may reasonably request to
effectuate such sale, assignment, transfer, conveyance and
delivery.
2.2 Purchase and Sale of
Transferred Assets .
(a) Subject to the
satisfaction or waiver of the conditions set forth in this
Agreement, at the Closing and as of the Closing Date, the Company
shall sell, transfer, convey, assign and deliver to the Buyer,
and/or the applicable Designated Purchaser, and the Buyer shall or
shall cause the applicable Designated Purchaser to purchase and
acquire, all of the Company’s and any of its
Subsidiaries’ right, title and interest in, to and under all
of the properties, assets, rights and claims used or held for use
principally in the conduct or operation of the Consumables Business
as the same may exist on the Closing Date, whether tangible or
intangible, and such other properties, assets, rights and claims
used or held for use principally in the conduct or operation of the
Process Business as may be specifically enumerated below (it being
understood that to the extent any of such properties, assets,
rights and claims are owned or held by the Transferred Subsidiaries
and are not Excluded Assets, such properties, assets, rights and
claims shall not be transferred pursuant to this Section
2.2(a)) , but rather by operation of law pursuant to the sale
of the Transferred Shares in accordance with Section 2.1 ),
including all right, title and interest of the Company and its
Subsidiaries in, to and under:
(i) (A) all billed and
unbilled accounts and notes receivable principally related to the
Consumables Business, all prepayments and prepaid expenses and
deposits related to each of the Consumables Business and all other
current assets principally related to the Consumables Business, and
the full benefit of any and all security for such accounts
receivable, notes receivable, prepayments, prepaid expenses and
other current assets and all Proceedings related to any such items,
and, as applicable,
10
with respect to all such
other items not principally related to the Consumables Business,
such items to the extent related to the Consumables Business; and
(B) all prepayments and prepaid expenses and deposits related to
the Process Business (other than (1) payments with respect to
insurance or Taxes and (2) deposits related to any facilities owned
or used principally in connection with the conduct or operation of
the Process Business that do not constitute Transferred
Assets);
(ii) all of the real property
set forth in Section 2.2(a)(ii) of the Company Disclosure
Schedule (the “ Owned Real Property ”),
including all of the land structures, buildings, improvements and
fixtures now or subsequently leased, located thereon or related
thereto;
(iii) all right, title and
interest in, to and under the Leases related to the Consumables
Business and identified in Section 4.1(i)(ii) of the Company
Disclosure Schedule (the “ Leased Real Property
” and together with the Owned Real Property, the “
Transferred Real Property ”), and all buildings,
structures and other improvements situated thereon;
(iv) all Inventory existing
on the Closing Date;
(v) all of the
Company’s and its Subsidiaries’ owned or leased
tangible personal property used or held for use principally in the
conduct or operation of the Consumables Business, including
machinery, mobile and immobile equipment, furniture, office
equipment, furnishings, transportation equipment, tools, tooling,
dies, parts, supplies and other tangible personal property and all
warranties or guarantees, if any, express or implied, existing for
the benefit of the Company, any of its Subsidiaries or the
Consumables Business with respect thereto;
(vi) all of the
Company’s and its Subsidiaries’ (A) manufacturing,
engineering and laboratory machinery, equipment (whether mobile or
immobile) and supplies, in whatever form, used or held for use
principally in the conduct or operation of the Process Business;
(B) demonstration equipment used or held for use principally in the
conduct or operation of the Process Business; and (C) all computer
equipment and information systems related to, or used or held for
use principally in, the conduct or operation of the Process
Business, and in each such case, all warranties or guarantees, if
any, express or implied, existing for the benefit of the Company,
any of its Subsidiaries or the Process Business with respect
thereto;
(vii) all right, title and
interest in, to and under all the Contracts to which the Company or
any of its Subsidiaries is a party, including all rights to receive
goods and services purchased pursuant to such Contracts and all
claims and rights to take any other actions arising out of or
related to such Contracts or the Transferred Assets, or in respect
thereof;
(viii) all of the
Company’s and any of its Subsidiaries’ right, title and
interest in and to any Intellectual Property;
11
(ix) all of the
Company’s and any of its Subsidiaries’ rights under any
Licenses and Permits to the extent transferable under applicable
Law and all rights under any licenses or permits from third parties
other than Governmental Authorities required to conduct each of the
Consumables Business and the Transferred Process Operations as it
is presently conducted or to own or use the Transferred
Assets;
(x) all Books and Records,
including any and all (A) subject to applicable Law, data and
records pertaining to the Transferred Subsidiary Employees, the US
Consumables Employees and the Process Business Employees and (B)
sales literature, promotional literature and other selling and
advertising material and lists of customers and
suppliers;
(xi) all rights under express
or implied warranties, representations or guarantees made by
suppliers furnishing goods or services;
(xii) all credits and
deferred charges related to, or arising in connection with, the
Consumables Business or the Transferred Process Operations,
including in connection with any Leases set forth in Section
4.1(i)(ii) of the Company Disclosure Schedule that constitute
Transferred Assets and rentals;
(xiii) all information
systems, hardware, telephone systems, software systems, database
and database systems used in the Consumables Business and any and
all rights thereunder, in each case, to the extent reflected as an
asset on the Consumables Business Balance Sheet or acquired after
the date thereof and which would reasonably be expected to be
reflected as an asset thereon if the Consumables Business Balance
Sheet were prepared as of the Closing Date;
(xiv) all insurance proceeds
received by the Company or any of its Subsidiaries in respect of
any Transferred Assets as a result of any damage or claim occurring
prior to Closing Date and any rights, claims or causes of action
existing or arising in respect of the Transferred Assets under the
Company’s insurance policies;
(xv) any assets relating to
the Liabilities assumed pursuant to Section 5.9(a)
;
(xvi) the goodwill and going
concern value of each of the Consumables Business and the Process
Business;
(xvii) all inventory backlog
relating to the Process Business existing and unfulfilled on the
Closing Date, including all unshipped and unfulfilled customer
product and service orders, all orders in progress and all other
obligations to deliver products which have not yet been performed
as of the Closing Date and for which, as of the Closing Date, a
bona fide receivable does not exist on the books of the Company or
otherwise for its benefit; and
(xviii) all other properties,
assets, rights and claims reflected on the Consumables Business
Balance Sheet or accrued after the date thereof and which would
reasonably be expected to be reflected thereon if the Consumables
Business Balance Sheet was prepared as of the Closing Date but not
otherwise described in this Section 2.2(a) .
12
(b) The properties, assets,
rights and claims to be purchased by Buyer and/or the Designated
Purchaser pursuant to this Section 2.2(b) , along with the
properties, assets, rights and claims enumerated in Section 2.2(b)
and the properties, assets, rights and claims of the Transferred
Subsidiaries which shall be transferred to the Buyer and/or the
Designated Purchaser through the sale of the Transferred Shares
pursuant to Section 2.1 , shall collectively be referred to
herein as the “Transferred Assets” . As of the
Closing, risk of loss as to the Transferred Assets shall pass from
the Company to the Buyer, except as may otherwise be expressly
provided herein. Notwithstanding Section 2.2(a) , the
Company shall retain all of its existing right, title and interest
in, to and under, and the Transferred Assets shall exclude the
following assets (the “ Excluded Assets
”):
(i) all cash and cash
equivalents;
(ii) all billed and unbilled
accounts and notes receivable principally related to the Process
Business and all other current assets principally related to the
Process Business, and the full benefit of any and all security for
such accounts receivable, notes receivable and other current assets
and all Proceedings related to any such items, and, as applicable,
with respect to all such other items not principally related to the
Process Business, such items to the extent related to the Process
Business;
(iii) all assets sold or
otherwise disposed of not in violation of any provisions of this
Agreement during the period from the date of this Agreement until
the Closing Date;
(iv) all income Tax Returns
of the Company and, subject to Section 6.6 , all Tax
refunds, Tax losses, Tax carryforwards, Tax credits and Tax
benefits of the Company;
(v) the minute books for the
board of directors, committees or shareholders’ meetings,
incorporation documents, stock transfers and Tax or similar or
related corporate records of the Company and its Subsidiaries,
other than the Transferred Subsidiaries;
(vi) all of the assets to be
transferred to the Company or one of its Subsidiaries, other than
the Transferred Subsidiaries, pursuant to the
Reorganization;
(vii) the real property
located at Tir-Y-Berth Industrial Estate, New Road, Hengoed,
Wales;
(viii) all of the
Company’s right, title and interest under this Agreement and
the Confidentiality Agreement; and
(ix) all assets of the
Company and its Subsidiaries, other than the Transferred
Subsidiaries, not used in connection with the operation of the
Consumables Business or the Transferred Process
Operations.
13
2.3 Assumption of
Liabilities .
(a) Subject to the
satisfaction or waiver of the conditions set forth in this
Agreement, at the Closing and as of the Closing Date, the Buyer
shall or shall cause the applicable Designated Purchaser to assume
and agree to pay, discharge or perform when due only the following
Liabilities (except to the extent that such Liabilities constitute
Liabilities of the Transferred Subsidiaries which shall be assumed
by the Buyer and/or the Designated Purchaser by operation of law
through its purchase of the Transferred Shares pursuant to
Section 2.1 ):
(i) all Liabilities related
to the Consumables Business and reflected on the balance sheet of
the Consumables Business dated as of December 31, 2004, which is
contained in Section 4.1(g)(i) of the Company Disclosure Schedule
(the “ Consumables Business Balance Sheet ”),
other than any Excluded Liabilities;
(ii) all other Liabilities
related to the Consumables Business incurred after the date of the
Consumables Business Balance Sheet not in violation of the terms of
this Agreement which would have been required to be reflected on
the Consumables Business Balance Sheet under GAAP if such
Liabilities were incurred on or prior to the date of the
Consumables Business Balance Sheet, other than any Excluded
Liabilities;
(iii) all Liabilities arising
under the Contracts (other than with respect to any Seller Plans)
to the extent such Liabilities (A) arise in the ordinary course of
business consistent with past practice pursuant to the terms of
such Contracts, (B) were not due to have been satisfied or
discharged prior to the Closing Date, and (C) have not arisen as a
result of a default or breach of such Contract by the Company or
its Subsidiaries;
(iv) all warranty Liabilities
to the extent such Liabilities (A) arise in the ordinary course of
business consistent with past practice under the terms of the
Contracts or under the Uniform Commercial Code and (B) were not due
to have been satisfied or discharged prior to the Closing
Date;
(v) all customer service and
support obligations following the Closing relating to the products
manufactured by the Process Business to the extent such obligations
(A) arise in the ordinary course of business consistent with past
practice under the terms of the Contracts related to the Process
Business or under the Uniform Commercial Code and (B) were not due
to have been satisfied or discharged prior to the Closing
Date;
(vi) all accounts payable
arising out of the operation of the Process Business prior to the
Closing Date and accrued in the ordinary course of business on the
balance sheet of the Process Business under GAAP as of the Closing
Date; provided, however , that the aggregate amount of such
accounts payable shall not exceed $350,000;
14
(vii) all Liabilities arising
as a result of the post-Closing operation of the Consumables
Business or the Transferred Process Operations or the post-Closing
ownership or use by the Buyer and its Subsidiaries of the
Transferred Assets; and
(viii) all Liabilities for
all earned but unpaid base salary, bonuses, vacation, sick leave
and unreimbursed business expenses that are accrued in the ordinary
course of business consistent with past practice and reflected on
the balance sheet of the Consumables Business or the Process
Business, as the case may be, under GAAP as of the Closing Date,
and which are not incurred in violation of Section 5.2 and are
payable to Closing Date Employees.
The Liabilities assumed by
Buyer and/or the Designated Purchaser pursuant to this Section
2.3(a) , along with the Liabilities which shall be assumed by
Buyer and/or the Designated Purchaser through the purchase of the
Transferred Shares pursuant to Section 2.1 , shall
collectively be referred to herein as the “ Assumed
Liabilities .”
(b) Neither the Buyer nor any
Designated Purchaser shall assume pursuant to this Agreement or the
transactions contemplated hereby any Liabilities of the Company or
any of its Subsidiaries other than the Assumed Liabilities, and the
Company and its Subsidiaries shall retain all such other
Liabilities, including:
(i) any claim or Liabilities
related to or arising out of the use or ownership of any Excluded
Assets;
(ii) Liabilities, whether of
the Transferred Subsidiaries or otherwise, to the Company or any
other Subsidiary or Affiliate of the Company;
(iii) any Liabilities of the
Company and the Transferred Subsidiaries, whether arising prior to,
on or after the Closing Date, to the extent arising from or as a
result of the conduct of any business of the Company or such
Transferred Subsidiaries other than the Consumables Business, other
than those expressly contemplated in Section 2.3(a) (iii) through
(viii);
(iv) claims or Liabilities
arising out of or otherwise with respect to or in connection with
the Reorganization;
(v) Liabilities relating to
any Consumables Business Employee or Process Business Employee,
whether or not arising under or in respect of any Company Plan,
other than those expressly assumed by the Buyer and/or the
applicable Designated Purchaser as set forth in Section 2.3(a)
(viii) and Section 5.9(a);
(vi) any Liability of the
Company or any Affiliate (other than the Transferred Subsidiaries)
of the Company for Taxes relating to any Pre-Closing Tax
Period;
(vii) Liabilities under or
relating to Environmental Laws to the extent relating to events or
conditions existing as of, or prior to, the Closing Date, other
than routine maintenance or similar obligations in the ordinary
course of business;
15
(viii) any Liability of the
Company or its Subsidiaries to any broker, finder or agent,
including SG Cowen & Co., LLC, for any investment banking or
brokerage fees, finder’s fees or commission with respect to
the transactions contemplated by this Agreement;
(ix) any Liability with
respect to a claim for personal injury (including wrongful death)
and/or property damage arising out of pre-Closing occurrences and
based on product liability, strict liability or other similar
theories of recovery, whether arising in contract or tort or
otherwise;
(x) any Liability with
respect to the wrongful discharge claim in France by the
Company’s former employee, which employee was an employee of
Argonaut Technologies, A.G.;
(xi) any Liability with
respect to the mass spectrometer referred to in Section
4.1(f)(1) of the Company Disclosure Schedule;
(xii) any other Liability
which the Company has expressly agreed to retain pursuant to the
provisions of this Agreement other than this Article II ;
and
(xiii) except to the extent
expressly set forth in Section 2.3(a) or elsewhere in this
Agreement, Liabilities relating to the Acquired Businesses, the
Transferred Assets, the Transferred Subsidiaries, the Transferred
Shares, the Process Business, the Process Business Employees or the
Consumables Business Employees or arising out of the operation or
ownership of the Acquired Businesses, the Transferred Subsidiaries
or the Transferred Shares or the employment of the Consumables
Business Employees or the Process Business Employees, in each case,
prior to the Closing Date.
The Liabilities retained by
the Company and its Subsidiaries pursuant to this Section
2.3(b) are referred to herein as the “ Excluded
Liabilities ”).
2.4 Transfer of Purchased
Assets and Assumed Liabilities . The Transferred Assets (other
than the properties, assets, rights and claims of the Transferred
Subsidiaries which shall be transferred through the purchase of the
Transferred Shares pursuant to Section 2.1 ) shall be sold,
conveyed, transferred, assigned and delivered, and the Assumed
Liabilities shall be assumed, pursuant to transfer and assumption
agreements or other instruments in such form as is necessary to
effect a conveyance of the Transferred Assets and an assumption of
the Assumed Liabilities in the jurisdictions in which such
transfers are to be made, and which shall be satisfactory to the
Buyer and the Company, to be executed (upon the terms and subject
to the conditions hereof) on the Closing Date by the Company and
the Buyer or the respective Designated Purchaser, and such other
conveyance and assumption documents as may be required in such
jurisdictions.
2.5 Procedures for Assets
Not Transferable . Notwithstanding anything to the contrary
contained in this Agreement, to the extent that the sale,
conveyance, transfer, assignment or delivery or attempted sale,
conveyance, transfer, assignment or delivery to the Buyer or any
Designated Purchaser of any Transferred Asset (but not any
Transferred Shares) is
16
prohibited by applicable Law or would
require any governmental or third-party authorizations, approvals,
consents or waivers (collectively, “ Consents ”)
the Company shall use its, and shall cause its Subsidiaries to use
their respective reasonable best efforts to obtain such Consents
prior to the Closing and if any such Consents shall not have been
obtained prior to the Closing, this Agreement shall not constitute
a sale, conveyance, transfer, assignment or delivery thereof if any
of the foregoing would constitute a breach of applicable Law or the
rights of any third party; provided , however , that
the Closing shall occur notwithstanding the foregoing on the terms
set forth herein; provided further , however , that
the Company shall not be relieved of its obligation to sell, and
the Buyer of its obligation to purchase, such Transferred Assets.
Following the Closing, the parties shall use their reasonable best
efforts and shall cooperate with each other to obtain promptly such
Consents. Pending or in the absence of such Consent, the parties
shall use their respective reasonable best efforts to implement an
alternative arrangement to permit the Buyer or the respective
Designated Purchaser, as the case may be, to realize, receive and
enjoy substantially similar rights and the full benefits of such
Transferred Asset as if such impediment to assignment or transfer
did not exist, and to enable Buyer or the respective Designated
Purchaser to conduct the Consumables Business or the Transferred
Process Operations, as the case may be, until such Consent is
obtained; provided , however , that after Closing,
the Company shall, and shall cause its Subsidiaries to, enforce,
upon and at the request of the Buyer and for the benefit of the
Buyer, any rights of the Company or its Subsidiaries arising with
respect to third parties party thereto. If such Consent is
obtained, the Company shall, and shall cause its Subsidiaries to,
promptly convey, transfer, assign and deliver, or cause to be
conveyed, transferred, assigned and delivered, such Transferred
Asset to the Buyer or such Designated Purchaser. The provisions of
this Section 2.5 shall not in any way limit the
Buyer’s rights under this Agreement in the event that the
conditions to Closing are not satisfied.
2.6 Payments
Post-Closing .
(a) If, following the Closing
Date, the Company or any of its Subsidiaries receives any payment
or other proceeds any portion of which relates to any Transferred
Assets, the Transferred Subsidiaries or otherwise relates to the
conduct or operation of the Consumables Business or the Transferred
Process Operations, including with respect to any receivables or
inventory backlog purchased by the Buyer in the Acquisition, the
Company shall, and shall cause its Subsidiaries to, promptly remit
to the Buyer the amount of any such payments to the extent relating
to the Transferred Assets, the Transferred Subsidiaries or the
Consumables Business or the Transferred Process
Operations.
(b) If, following the Closing
Date, the Buyer or any of its Subsidiaries receives any payment or
other proceeds any portion of which relates to any Excluded Assets
or otherwise relates to the conduct or operation of the Company and
its Subsidiaries other than the Consumables Business or the
Transferred Process Operations, the Buyer shall, and shall cause
its Subsidiaries to, promptly remit to the Company the amount of
any such payments to the extent relating to the Excluded Assets or
such other business.
17
ARTICLE III
PURCHASE PRICE AND
ADJUSTMENTS
3.1 Purchase Price .
Subject to any adjustments required pursuant to Sections 3.2
and 3.3 , the aggregate purchase price for the Transferred
Shares and the Transferred Assets shall be an amount equal to
$21,200,000 (Twenty-One Million, Two Hundred Thousand Dollars) (the
“ Purchase Price ”), payable in cash by wire
transfer of immediately available funds to an account designated by
the Company at least two (2) Business Days prior to
Closing.
3.2 Payment of Purchase
Price and Estimated Purchase Price Adjustment
(a) Escrow . At the
Closing, the Buyer shall pay out of the Purchase Price $2,000,000
(Two Million Dollars) (the “ Escrow Funds ”) to
be held in an escrow account in accordance with the terms of the
Escrow Agreement to be executed prior to Closing in the form of
Exhibit B , $1,000,000 (One Million Dollars) of which Escrow
Funds shall be available for the Buyer to satisfy claims under
Section 10.1(a) (other than Section 10.1(a)(iv) ) and
$1,000,000 (One Million Dollars) of which shall be available to
satisfy claims under Section 10.1(a)(iv) , including to make
any payment with respect to the UK Tax Liability, if any. In the
event that the UK Tax Proceeding is finally resolved, which
resolution shall be in accordance with the procedures prescribed by
Section 6.1 , within one (1) year of the Closing Date, and
the amount paid, if any, with respect thereto is less than
$1,000,000 (One Million Dollars), the Buyer shall instruct the
escrow agent to (i) pay any amounts owed in respect of the UK Tax
Liability to the party to which it is due, (ii) deliver to the
Company an amount equal to the excess of $1,000,000 (One Million
Dollars) over the amount paid to finally settle and resolve the UK
Tax Liability, if any, and (iii) deliver the remaining Escrow
Funds, if any, within three (3) Business Days after the date that
is one (1) year after the Closing Date (such one (1) year and three
(3) Business Day period, as extended by this sentence, the “
Initial Closing Escrow Period ”), except that such
period shall be increased, if at all, to the extent that the Buyer
has become aware of the assertion of any claim or of the
commencement of any Proceeding at law or in equity as to which it
is entitled to indemnification hereunder and has notified the
Company thereof in accordance with Article X prior to the
end of the Closing Escrow Period until such time as all such claims
have been finally resolved in accordance with the procedures set
forth in the Escrow Agreement. In addition, in the event that the
UK Tax Proceeding is not finally resolved within the Initial
Closing Escrow Period, in addition to any other Escrow Funds being
held by the Escrow Agent with respect to any unresolved claims
(other than the UK Tax Proceeding), $1,000,000 of the Escrow Funds
shall continue to be held by the escrow agent and be available for
the Buyer in respect of the UK Tax Liability until such time as the
UK Tax Proceeding is finally resolved in accordance with the
procedures prescribed in Section 6.1 . Upon such resolution
in accordance with the procedures prescribed in Section 6.1
, and after payment of the Escrow Funds in satisfaction of the UK
Tax Liability, if any, and resolution and payment of all other
remaining claims, any remaining Escrow Funds shall be distributed
to the Company, subject to the terms of the Escrow
Agreement.
(b) Estimated Purchase
Price Adjustment . No later than three (3) Business Days prior
to the Closing Date, the Company shall deliver to the Buyer a
statement (the “ Preliminary Closing Date Net Working
Capital Statement ”) setting forth the Company’s
good faith
18
estimate (the “ Preliminary
Closing Date Net Working Capital ”) of (i) the total
Inventory of the Consumables Business plus (ii) the total
accounts receivable of the Consumables Business minus (ii)
the total accounts payable of the Consumables Business, in each
case, calculated as of the Closing Date (the “ Closing
Date Net Working Capital ”), calculated in accordance
with GAAP, the methodology used in preparing the Consumables
Business Balance Sheet and Section 3.2(b) of the Company
Disclosure Schedule, which shall be certified by the
Company’s chief financial officer (for the avoidance of
doubt, the accounts receivable and accounts payable of the
Consumables Business shall include all such accounts with respect
to the Quest, Trident and Nautalis Discontinued Systems,
Consumables and Services line of the Consumables Business). In the
event that the Buyer does not agree with the Company’s
estimate, the Company and the Buyer shall negotiate in good faith
to mutually agree as promptly as practicable on an acceptable
estimate of the Preliminary Closing Date Net Working Capital
Statement. At the Closing, the amount of the Purchase Price that
the Buyer shall be required to pay to the Company pursuant to this
Agreement shall be adjusted by the difference between the
Preliminary Closing Date Net Working Capital and the Target Net
Working Capital. If the Preliminary Closing Date Net Working
Capital exceeds the Target Net Working Capital, the amount of the
Purchase Price paid by the Buyer to the Company at Closing shall be
increased dollar-for-dollar by the amount of such excess, and if
the Preliminary Closing Date Net Working Capital is less than the
Target Net Working Capital, the amount of the Purchase Price paid
at the Closing shall be decreased dollar-for-dollar by such
shortfall, a portion of which shall be paid to the escrow agent
pursuant to paragraph (a) above. The Purchase Price shall
thereafter be subject to further adjustment as provided in
Section 3.3 .
3.3 Closing Date Net
Working Capital Statement; Schedule of Cash and Cash Equivalents;
and Actual Adjustment Amount .
(a) No later than sixty (60)
days after the Closing Date, the Company shall prepare (i) a
balance sheet of the Consumables Business, which balance sheet
shall be prepared in accordance with GAAP, the methodology used in
preparing the Consumables Business Balance Sheet and Section
3.2(b) of the Company Disclosure Schedule (the “
Closing Statement ”), (ii) a statement of the actual
Closing Date Net Working Capital (such statement, as finally
determined pursuant to the provisions of this Section 3.3 ,
the “ Closing Date Net Working Capital Statement
”), which statement shall be prepared in accordance with
GAAP, the methodology used in preparing the Consumables Business
Balance Sheet and Section 3.2(b) of the Company Disclosure
Schedule, (iii) a statement of the actual cash and cash equivalents
held by the Transferred Subsidiaries as of the Closing Date (such
statement, as finally determined pursuant to the provisions of this
Section 3.3 , the “ Closing Date Cash Statement
”), which Closing Date Net Working Capital Statement and
Closing Date Cash Statement shall be prepared in accordance with
GAAP, the methodology used in preparing the Consumables Business
Balance Sheet and Section 3.2(b) of the Company Disclosure
Schedule, and derived from the Closing Statement, and (iv) a
statement setting forth the aggregate dollar amount of the accounts
payable of the Process Business transferred to the Buyer at Closing
(the “ Accounts Payable Statement ”). The Buyer
shall cooperate with the Company and its accountants to the extent
required to enable the Company to prepare the Closing Statement,
the Closing Date Net Working Capital Statement, the Closing Date
Cash Statement and the Accounts Payable Statement in accordance
with this Agreement. In connection with the preparation of the
Closing Date Net Working Capital Statement, the Buyer and the
Company shall jointly conduct a
19
physical inventory count of the
Inventory of the Consumables Business (the “ Inventory
Count ”), including all raw materials, work-in-process,
finished products, supplies, accessories, packaging materials,
goods or parts, in each case that are (i) used or held for use
principally in the conduct or operation of the Consumables Business
by the Company or its Subsidiaries (including the Transferred
Subsidiaries) or (ii) in the possession of third parties,
commencing at a mutually agreed upon date within ten (10) days
prior to the Closing Date and be reconciled to, and completed by,
the Closing Date. Any disputes with respect to the Inventory Count
shall be submitted to the Independent Accounting Firm in accordance
with the provisions of Section 3.3(c) .
(b) The Buyer may dispute the
Closing Date Net Working Capital Statement, the Closing Date Cash
Statement, the Closing Statement and the Accounts Payable Statement
by notifying the Company within thirty (30) days after its receipt
thereof. During such 30-day period, and until the Closing Date Net
Working Capital Statement, the Closing Date Cash Statement, the
Closing Statement and the Accounts Payable Statement are finally
determined, employees of the Buyer and its accountants shall be
entitled to access to the Company’s and its
accountants’ work papers prepared in connection with the
Closing Date Net Working Capital Statement, the Closing Date Cash
Statement, the Closing Statement and the Accounts Payable Statement
and shall be entitled to review and discuss such work papers with
the Company and its accountants. Any notice delivered in accordance
with this Section 3.3(b) shall specify in reasonable detail
the nature of any disagreement so asserted. If the Buyer does not
so notify the Company within such period, the Closing Date Net
Working Capital Statement, the Closing Date Cash Statement, the
Closing Statement and the Accounts Payable Statement shall be
final, binding and conclusive on the parties. If the Buyer does so
notify the Company, the Buyer and the Company and their respective
accountants shall attempt to reconcile their differences, and any
resolution by them as to any disputed amounts shall be final,
binding and conclusive on the parties thereto.
(c) If the Buyer and the
Company are unable to reach a resolution with respect to all of the
items specified in a notice provided pursuant to Section
3.3(b) within twenty (20) days after receipt by the Company of
such notice, then either party may submit the items remaining in
dispute for resolution to KPMG LLP, provided that if at such time
either party has a conflict with respect to KPMG LLP, the parties
shall select another mutually acceptable firm (such firm, the
“ Independent Accounting Firm ”), which shall,
within twenty (20) days after such submission or such longer period
as the Independent Accounting Firm may reasonably require,
determine and report to the Buyer and the Company upon such
remaining disputed items, and such determination shall be final,
binding and conclusive on the parties hereto. The fees and
disbursements of the Independent Accounting Firm shall be allocated
between the Buyer and the Company in such manner that the Buyer
shall be responsible for that portion of the fees and expenses
equal to such fees and expenses multiplied by a fraction the
numerator of which is the aggregate dollar value of disputed items
submitted to the Independent Accounting Firm that are resolved
against the Buyer (as finally determined by the Independent
Accounting Firm) and the denominator of which is the total dollar
value of the disputed items so submitted, and the Company shall be
responsible for the remainder of such fees and expenses.
(d) Following the
determination of the Closing Date Net Working Capital pursuant to
this Section 3.3 , (i) if the Closing Date Net Working
Capital exceeds the Preliminary
20
Closing Date Net Working Capital, (A)
the Purchase Price shall be increased dollar-for-dollar by the
amount of such surplus (the “ Surplus ”) and (B)
the Buyer shall pay to the Company the Surplus, with interest
thereon as calculated pursuant to Section 3.3(e) plus the
total amount reflected on the Closing Date Cash Statement, (ii) if
the Closing Date Net Working Capital is less than the Preliminary
Closing Date Net Working Capital, (A) the Purchase Price shall be
decreased dollar-for-dollar by such deficiency (the “
Deficiency ”) and (B) (x) if the total amount
reflected on the Closing Date Cash Statement is greater than the
amount of the Deficiency, the Buyer shall pay to the Company the
excess of the total amount reflected on the Closing Date Cash
Statement over the Deficiency, or, (y) if the total amount
reflected on the Closing Date Cash Statement is less than the
amount of the Deficiency, the Company shall pay to the Buyer the
excess of the Deficiency over the total amount reflected on the
Closing Date Cash Statement, and (iii) if the Closing Date Net
Working Capital is the same as the Preliminary Closing Date Net
Working Capital, the Buyer shall pay to the Company the total
amount reflected on the Closing Date Cash Statement, in each case
with interest thereon as calculated pursuant to Section
3.3(e) , in each case, within five (5) Business Days after the
Buyer and the Company agree to the Closing Date Net Working Capital
and the Closing Date Cash Statement or within five (5) Business
Days after the Independent Accounting Firm finally determines the
Closing Date Net Working Capital and the Closing Date Cash
Statement. In the event the amount of the accounts payable of the
Process Business on the Closing Date calculated in accordance with
GAAP and as finally determined pursuant to this Section 3.3
is greater than $350,000, the excess over $350,000 shall be
subtracted from any amounts owed by the Buyer to the Company
pursuant to this Section 3.3(d) or added to any amounts owed
by the Company to the Buyer pursuant to this Section 3.3(d)
, as the case may be. Any Surplus or Deficiency, as applicable,
together with interest thereon, and any payment with respect to the
Closing Date Cash Statement payable pursuant to this Agreement
shall be treated for tax purposes as an adjustment to the Purchase
Price.
(e) The party making such
payment pursuant to Section 3.3(d) , shall pay interest
thereon to the other party for the period from the Closing Date to
the date of payment at the London Inter-Bank Offer Rate (“
LIBOR ”) for six (6) month deposits in U.S. dollars as
quoted on Telerate Page 3750 on the Closing Date. Such payment and
interest thereon shall be made by wire transfer in immediately
available funds to such account or accounts as are designated in
writing by the party entitled to receive such payment no later than
the second Business Day prior to the date on which such payment is
due.
3.4 Allocation of Purchase
Price . The Buyer and the Company agree to allocate the
Purchase Price (and any Liabilities assumed hereunder that are
properly treated as purchase price) in accordance with the rules
under Section 1060 of the Code and the Treasury Regulations
promulgated thereunder. Such allocation shall be mutually agreed
upon between the parties. The Buyer and the Company agree to act in
accordance with the computations and allocations as determined
pursuant to this Section 3.4 in any relevant Tax Returns or
filings, including any forms or reports required to be filed
pursuant to Section 1060 of the Code, the Treasury Regulations
promulgated thereunder or any provisions of local, state and
foreign law (“ 1060 Forms ”), and to cooperate
in the preparation of any 1060 Forms and to file such 1060 Forms in
the manner required by applicable law. Any issues with respect to
the allocation which have not been finally resolved within 60 days
following Closing shall be referred to the Independent Accounting
Firm in accordance with the provisions of Section 3.3(c) .
Notwithstanding
21
the foregoing, the Buyer and the Company
shall agree to a tentative allocation of the Purchase Price (and
any Assumed Liabilities) between the Transferred Shares, on the one
hand, and the Transferred Assets, on the other hand, within 20 days
after the Amendment Date, and if the parties cannot mutually agree
upon such a tentative allocation, such tentative allocation shall
be prepared by the Buyer in good faith.
ARTICLE IV
REPRESENTATIONS AND
WARRANTIES
4.1 Representations and
Warranties of the Company . Except as set forth in applicable
section of the Company Disclosure Schedule and subject to Section
11.15, the Company hereby represents and warrants to Buyer as
follows:
(a) Due Organization .
Each of the Company and each of its Subsidiaries is a corporation
duly organized, validly existing and, where applicable, in good
standing under the laws of the jurisdiction of its organization.
Each of the Company and each of its Subsidiaries (i) has all
requisite corporate power and authority to own, lease and operate
all of its properties and assets and to carry on its business as it
is now being conducted and (ii) is in good standing and is duly
qualified to do business in each jurisdiction in which the nature
of its business or the ownership, leasing or operation of its
properties makes such qualification necessary, except where the
failure to so qualify or be in good standing, individually or in
the aggregate, has not had, and would not reasonably be expected to
have, a Material Adverse Effect. The copies of the certificate of
incorporation and by-laws or similar organizational documents of
the Company and the Transferred Subsidiaries which were previously
made available to the Buyer, are true, complete and correct copies
of such documents as in effect on the date of this Agreement. The
register of members of the Transferred Subsidiaries contain
accurate records of the members of the Transferred Subsidiaries and
the Transferred Subsidiaries have not received any notice of any
application or intended application for rectification. The
statutory books of the Transferred Subsidiaries and their registers
are up to date in all material respects and contain records which
are complete and accurate in all material respects of all matters
required to be dealt with in such books.
(b) Subsidiaries
.
(i) Except for the
Transferred Shares, the Company does not own or hold, directly or
indirectly, any equity interest of any kind in any Person that owns
assets or properties or conducts operations used or held for use in
the Consumables Business or the Transferred Process Operations. All
of the Transferred Shares and all of the shares of capital stock of
the other Transferred Subsidiaries have been duly authorized and
validly issued and are fully paid-up and non-assessable, to the
extent such terms are applicable, with no personal liability
attaching to ownership thereof, and such shares or other securities
are owned by the Company or, in the case of the other Transferred
Subsidiaries, the Transferred Subsidiary, in each case free and
clear of any Lien. Upon consummation of the transactions
contemplated hereby, the Buyer and/or the Designated Purchaser
will
22
acquire good and valid title
to the Transferred Shares free and clear of all Liens. Except for
this Agreement there are no outstanding options, warrants, stock
appreciation rights, rights to subscribe to, calls, rights of first
offer, rights of first refusal or commitments of any character
whatsoever relating to, or securities or rights convertible into or
exercisable or exchangeable for, shares of any capital stock or
other equity securities of the Transferred Subsidiaries, and there
are no Contracts or other arrangements by which the Transferred
Subsidiaries may be or become bound to issue additional shares of
its capital stock or other equity securities, or options, warrants
or rights to purchase, acquire, subscribe to, calls on, or rights
of first offer, rights of first refusal or commitments for, any
shares of its capital stock or other equity securities.
(ii) Neither the Company nor
any of its Subsidiaries has, owns or controls (of record or
beneficially), directly or indirectly, any interest in any other
Person, or is a party to or participant in any partnership, joint
venture or other similar investment related to the Consumables
Business or the Transferred Process Operations. Neither the Company
nor any of its Subsidiaries is subject to any obligation or
requirement to provide funds to or make any investment (whether in
the form of a loan, capital contribution or otherwise) in any
Person related to the Consumables Business or the Transferred
Process Operations.
(iii) The authorized capital
stock of the Transferred Subsidiary consists of 500,000 ordinary
shares of 100 pence each. At the close of business on February 15,
2005, 179,018 shares were outstanding and no shares were held in
treasury. Section 4.1(b)(iii) of the Company Disclosure
Schedule sets forth (i) the authorized capital stock of each of the
Transferred Subsidiaries (other than the Transferred Subsidiary)
and the par value of such shares, to the extent applicable, and
(ii) the number of shares of such capital stock outstanding and
number of shares held in treasury, in each case, for each of the
Transferred Subsidiaries (other than the Transferred Subsidiary) as
of February 15, 2005. The Transferred Subsidiary owns all of the
shares of capital stock of each of the other Transferred
Subsidiaries. There are no outstanding obligations of the
Transferred Subsidiaries to repurchase, redeem or otherwise acquire
any shares of capital stock of the Transferred Subsidiaries or
pursuant to which the Transferred Subsidiaries is or could be
required to register any shares of its capital stock or any other
securities under the Securities Act or under any other Laws. No
bonds, debentures, notes or other indebtedness having the right to
vote, or being convertible into or exercisable or exchangeable for
any securities having the right to vote, on any matters on which
stockholders may vote (“ Voting Debt ”) of the
Transferred Subsidiaries are issued or outstanding.
(c) Authorization and
Validity of Agreement . The Company has all requisite corporate
power and authority to enter into this Agreement and to consummate
the transactions contemplated hereby. The execution, delivery and
performance by the Company of this Agreement and the consummation
by the Company of the transactions contemplated hereby have been
duly and validly authorized by all necessary corporate action and
no other corporate action or proceeding on the part of the Company
is or will be necessary for the execution, delivery and performance
by the Company of this Agreement and the consummation by the
Company of the transactions contemplated hereby (other than the
approval of the Acquisition and the
23
consummation of the transactions
contemplated by this Agreement by the affirmative vote of the
holders of a majority of the outstanding stock of the Company
entitled to vote thereon (the “ Stockholder Approval
”). This Agreement has been duly and validly executed and
delivered by the Company and, assuming the due authorization,
execution and delivery hereof by the Buyer, constitutes a legal,
valid and binding obligation of the Company, enforceable against it
in accordance with its terms, except to the extent that its
enforceability may be limited by bankruptcy, insolvency,
reorganization, moratorium or other laws relating to or affecting
creditors’ rights generally and by general equity principles
(whether considered in a proceeding in equity or at law). The
Company’s Board of Directors, by resolutions duly adopted at
a meeting duly called and held, has (i) determined that the
Acquisition and the transactions contemplated by this Agreement are
expedient and in the best interests of the Company and its
stockholders and declared the Acquisition and the transactions
contemplated by this Agreement advisable, (ii) approved this
Agreement and the transactions contemplated by this Agreement,
including the Acquisition, and (iii) recommended that the
stockholders of the Company approve this Agreement and the
consummation of the transactions contemplated hereby and directed
that such matter be submitted for consideration by the stockholders
of the Company at the meeting of the stockholders to obtain the
Stockholder Approval. The only vote of the stockholders of the
Company required to approve the Acquisition and the consummation of
the transactions contemplated by this Agreement is the Stockholder
Approval.
(d) No Conflict . The
execution and delivery of this Agreement does not, and the
consummation of the transactions contemplated hereby and compliance
with the terms hereof will not, (i) conflict with, or result in any
violation of, or constitute a default (with or without notice or
lapse of time or both) under, or give rise to a right of
termination, cancellation, acceleration or increase of any
obligation, liability or fee or the loss of a material benefit
under, or the creation of a Lien on the Transferred Assets (any
such conflict, violation, default, right of termination,
cancellation or acceleration, loss or creation, a “
Violation ”) pursuant to, any provision of the
certificate of incorporation or by-laws of the Company or any of
its Subsidiaries, (ii) result in any Violation of any of the
Contracts or any other material contract to which the Company or
any of its Subsidiaries is a party, or (iii) result in any
Violation of any Licenses and Permits, Order or Law applicable to
the Consumables Business, the Transferred Process Operations, the
Transferred Assets or the Transferred Subsidiaries or their
respective properties, rights or assets or otherwise applicable to
the Company, except in the case of clauses (ii) and (iii) for any
Violation which, individually or in the aggregate, has not had, and
would not reasonably be expected to have, a Material Adverse
Effect.
(e) Consents . No
consent, approval, Order, Licenses and Permits, or registration,
declaration or filing with, or notice to, any Governmental
Authority or of, with or from any other Person, is required in
connection with the execution and delivery of this Agreement by the
Company or the consummation by the Company of the transactions
contemplated hereby, except for (i) the filing with the SEC of the
Proxy Statement (as defined herein) and the filing with the SEC of
such reports and other materials under the Exchange Act as may be
required in connection with this Agreement and the transactions
contemplated hereby, and (ii) such other consents, approvals,
Orders, Licenses and Permits, registrations and filings which, if
not obtained or made, individually or in the aggregate, would not
reasonably be expected to interfere in any material respect with
the conduct of the Consumables Business or the Transferred Process
Operations as currently conducted.
24
(f) Conduct of the
Consumables Business and the Transferred Process Operations .
Except as expressly contemplated hereby, since September 30, 2004
(or as otherwise indicated in subclause (ii) below) to the date of
this Agreement, (i) the Company and its Subsidiaries have conducted
the operations of the Consumables Business and the Transferred
Process Operations only in the ordinary course of business
consistent with past practice, (ii) have not taken any action that
would have been prohibited by Section 5.2 if this Agreement
had been in effect at the time such action was taken (other than
with respect to subclauses (ix) and (xi) (excluding the proviso) in
which case the reference date shall be December 31, 2004, and
subclause (xxii) which shall not be deemed covered by this
representation) and (iii) there has not been any Material Adverse
Effect.
(g) Financial Statements;
Undisclosed Liabilities .
(i) As of their respective
dates of filing with the SEC (or, if amended or superseded by a
filing prior to the date hereof, as of such filing), all of the
reports, prospectuses, registrations statements, proxy and
information statements and all other documents required to be filed
by the Company with the SEC since January 1, 2002 (including all
exhibits and schedules thereto and documents incorporated by
reference therein, the “ Company SEC Documents
”) complied as to form in all material respects with the
applicable requirements of the Securities Act, the 1934 Act and the
Sarbanes-Oxley Act of 2002 and the related rules and regulations
promulgated thereunder, as the case may be, and none of the Company
SEC Documents when filed contained any untrue statement of material
fact or omitted to state a material fact required to be stated
therein or necessary to make the statements therein, in light of
the circumstances under which they were made, not
misleading.
(ii) Section 4.1(g)(i)
of the Company Disclosure Schedule contains a true and complete
copy of the (A) unaudited Consumables Business Balance Sheet and
(B) the Argonaut Technologies, Inc. Worldwide 2004 Unaudited
Revenue Split Statement (collectively, the “ Financial
Statements ” ) . The Financial Statements present
fairly, in all material respects, on a pro forma basis, the
financial condition and results of operations of the Consumables
Business as of the respective dates and for the respective periods
indicated therein. The Financial Statements were prepared from, and
are in accordance with, the Books and Records of the Consumables
Business and using the same methodologies and principles as used to
prepare the financial statement filed by the Company with the SEC,
except as expressly stated therein. The Financial Statements have
been prepared based on management’s good faith belief of the
results, and/or financial position, of the Consumables
Business.
(iii) All of the Liabilities
reflected on the Consumables Business Balance Sheet are related to
the Consumables Business and arose out of or were incurred in the
ordinary course of business. Except (i) to the extent reflected or
reserved against in the Consumables Business Balance Sheet, or (ii)
for Liabilities that are incurred after the date of the Consumables
Business Balance Sheet in the ordinary course of business, there
are no material Liabilities or other obligations of any nature
whatsoever relating to the Consumables Business.
25
(iv) The Accounts of the
Transferred Subsidiaries incorporated in England and
Wales:
(A) have been prepared in
accordance with the generally accepted accounting practice commonly
adopted by companies carrying on businesses similar to those
carried on by such Transferred Subsidiaries in the United Kingdom
as of the Accounts Date;
(B) show a true and fair view
of the state of affairs of such Transferred Subsidiaries as of the
Accounts Date and of their respective profits or losses for the
accounting reference period ended on that date;
(C) comply with the
requirements of the United Kingdom Companies Act 1985, as amended;
and
(D) (except as the Accounts
expressly disclose) are prepared using estimation techniques and
accounting policies which are the same in all material respects as
those adopted in preparing the Previous Accounts.
(v) Since the Accounts Date
apart from the dividends provided for in the Accounts, no dividend
or other distribution has been declared, paid or made by the
Transferred Subsidiaries incorporated in England and
Wales.
(vi) Section
4.1(g)(vi) of the Company Disclosure Schedule contains a true
and complete copy of the unaudited balance sheet of the Process
Business dated as of December 31, 2004 (the “ Process
Business Balance Sheet ”). The Process Business Balance
Sheet presents fairly, in all material respects, on a pro forma
basis, the financial condition of the Process Business as of the
respective dates and for the respective periods indicated therein.
The Process Business Balance Sheet was prepared from, and is in
accordance with, the Books and Records of the Process Business
using the same methodologies and principles as used to prepare the
financial statement filed by the Company with the SEC, except as
expressly stated therein. The Process Business Balance Sheet has
been prepared based on management’s good faith belief of the
results, and/or financial position, of the Process
Business.
(h) Takeover Statutes
. The Company has taken all corporate action necessary to render
inapplicable to this Agreement and the transactions contemplated
hereby the restrictions on business combinations set forth in
Section 203 of the DGCL and any similar Laws.
(i) Properties
.
(i) The Owned Real Property
is all of the real property legally and beneficially owned by the
Company or any of its Subsidiaries and used in connection with the
Consumables Business (other than the real property located at
Tir-Y-Berth Industrial Estate, New Road, Hengoed, Wales) and
neither the Company nor any Transferred Subsidiary has any estate,
right, interest or Liability in any other land. The Company or one
of the Transferred Subsidiaries has good, marketable and insurable
fee simple title to the Owned Real Property, free and clear of all
Liens other than Permitted Liens. The existing use of each parcel
of Owned Real Property is the lawful use. Neither the
26
Company nor the Transferred
Subsidiaries has disposed of, or taken any steps to dispose of, the
Owned Real Property and are not under any commitment to dispose of
it in whole or in part. All certificates of occupancy, permits,
licenses, approval and authorizations (collectively, the “
Real Property Permits ”) of all Governmental
Authorities having jurisdiction over the Owned Real Property or any
portion thereof have been obtained and are in full force and effect
to operate and occupy such Owned Real Property, except to the
extent the absence or invalidity of any Real Property Permit does
not materially and adversely affect the value or operation and
occupancy of such Owned Real Property. As of the date hereof,
neither the Company nor the Transferred Subsidiaries has received
any written notice from any Governmental Authority having
jurisdiction over any of the Owned Real Property suspending,
revoking or canceling any Real Property Permit, or modifying any
Real Property Permit in a manner which materially and adversely
affects the operation of the Consumables Business or the occupancy
of the Owned Real Property. As of the date hereof, there are no
disputes, actions or orders pending, or to the Knowledge of the
Company, threatened against or relating to the condemnation, use,
occupation or condition of the Owned Real Property (whether
contingent or otherwise), or any portion thereof.
(ii) Section
4.1(i)(ii) of the Company Disclosure Schedule contains a
complete and accurate list of (A) all real property leased by the
Company and its Subsidiaries in connection with the operation of
the Consumables Business, (B) all real property leased by the
Company and its Subsidiaries in connection with the operation of
the Process Business and (C) the agreements under which such real
property is leased (the “ Leases ”). Except as,
individually or in the aggregate, has not had, and would not
reasonably be expected to interfere in any material respect with
the conduct of the Consumables Business, (A) each Lease has been
executed and is in full force and effect, (B) none of the Company
or any of its Subsidiaries is in breach or default in any respect
under any such Lease, and, to the Knowledge of the Company, no
event has occurred which, with notice or lapse of time or both,
would constitute such a material breach or default of such Lease,
(C) each Lease will continue to be binding in accordance with its
terms immediately following the Closing, except those Leases which
would no longer be binding as a result of actions that are taken by
the Buyer or its Affiliates, and (D) to the Knowledge of the
Company, no party to such Lease is in breach or default under such
Lease or has repudiated any material provision thereof.
(iii) Where necessary, (A)
all titled deeds are either (1) fully stamped with ad valorem stamp
duty and a particulars delivered stamp or (2) accompanied by a
valid certificate from the Inland Revenue evidencing submission of
a land transaction return and (B) all documents of title include
the consents for the grant of the Leases.
(j) Title to Transferred
Assets; Sufficiency of Assets . The Company or one of the
Transferred Subsidiaries has good, valid and marketable title, of
record and beneficially, to all of the Transferred Assets and at
the Closing will transfer and deliver to the Buyer and/or the
respective Designated Purchaser legal and valid title to the
Transferred Assets, free and clear of all Liens, other than
Permitted Liens. The Transferred Assets constitute all of the
assets necessary for the Buyer (i) to conduct the Consumables
Business in the manner in which it is currently being conducted and
(ii) to satisfy the Liabilities it is assuming relating to the
Process
27
Business in due course. All of the
machinery, equipment and other tangible assets included in the
Transferred Assets are in good and usable condition, ordinary wear
and tear excepted, have been maintained in accordance with normal
industry practice and are otherwise suitable for the purposes for
which they are currently used.
(k) Taxes .
(i) All material Tax Returns
required to be filed by each of the Transferred Subsidiaries or in
connection with the Acquired Businesses have been timely filed. All
material Taxes required to be paid (whether or not shown to be due
on such Tax Returns) by each of the Transferred Subsidiaries or in
connection with the Acquired Businesses have been timely paid. All
such Tax Returns are true, correct and complete in all material
respects.
(ii) There is no material
Proceeding, investigation, audit or examination proposed in writing
or currently ongoing against or with respect to any of the
Transferred Subsidiaries or in connection with the Acquired
Businesses in respect of any Tax. No deficiencies for any Taxes
have been proposed, asserted or assessed against any of the
Transferred Subsidiaries or in connection with the Acquired
Businesses.
(iii) All Taxes required to
have been withheld by each of the Transferred Subsidiaries or in
connection with the Acquired Businesses have been withheld and paid
over to the proper Governmental Authority.
(iv) There are no material
Liens for Taxes upon any property or assets of any of the
Transferred Subsidiaries or the Acquired Businesses (other than for
Taxes not yet due and payable).
(v) None of the Transferred
Subsidiaries has any material liability for the Taxes of any Person
(other than the Transferred Subsidiaries) including (A) under
section 1.1502-6 of the Treasury Regulations (or any similar
provision of state, local or foreign law), (B) as a transferee or
successor or (C) by Contract.
(vi) None of the Transferred
Subsidiaries is a party to, is bound by or has any obligation
under, any tax sharing agreement or similar Contract or any
agreement that obligates it to make any payment computed by
reference to the taxes, taxable income or taxable losses of any
other Person.
(vii) None of the Transferred
Subsidiaries have within the last six (6) years acquired any asset
from any other company (other than another of the Transferred
Subsidiaries) which was, at the time of such acquisition, a member
of the same group of companies as the relevant Transferred
Subsidiary for the purposes of any Tax.
(viii) No liability for Taxes
or deficit for any Tax purposes would arise for any of the
Transferred Subsidiaries from the loan relationships to which the
relevant Transferred Subsidiary is party being repaid to the extent
of the amounts shown in respect of such loan relationships in the
books of the relevant Transferred Subsidiary as of the date
hereof.
28
(ix) Each of the Transferred
Subsidiary and International Sorbent Technology Limited is a
registered and taxable person for the purposes of the United
Kingdom Value Added Tax Act 1994 and neither is nor has ever been
treated for such purposes as a member of a group for the purposes
of United Kingdom value added tax.
(x) All documents in the
possession or under the control of the Transferred Subsidiaries or
to the production of which any of the Transferred Subsidiaries are
entitled which are necessary to establish title to any asset or to
effect registration in respect of the holding of an asset or to
produce the relevant instrument as evidence in civil proceedings or
in a hearing before an arbitrator or referee and which, in the
United Kingdom or elsewhere, attract either stamp duty or transfer
Tax or require to be stamped with a particular stamp denoting that
no duty is chargeable or that the document has been produced to the
appropriate authority, have been properly stamped or the transfer
Tax duly paid and there are no circumstances in which any of the
Transferred Subsidiaries will or may after Closing be liable to pay
an amount of United Kingdom stamp duty land tax, submit a United
Kingdom stamp duty land transaction return or a United Kingdom
stamp duty land tax self certificate in respect of any transaction
entered into or action taken prior to Closing.
(xi) None of the Transferred
Subsidiaries is liable to Tax in any jurisdiction other than the
jurisdiction in which it is incorporated, and none of the
Transferred Subsidiaries or the Company has or has ever had a
permanent establishment in a jurisdiction other than the
jurisdiction of its incorporation.
(l) Legal Proceedings
. There are no Proceedings which are pending or, to the Knowledge
of the Company, threatened against, affecting or involving the
Company, the Consumables Business, the Process Business, any of the
Transferred Assets or any of the Transferred Subsidiaries or
challenging the validity of this Agreement or any of the
transactions contemplated hereby which, individually or in the
aggregate, has had, or would reasonably be expected to have, a
Material Adverse Effect. Neither the Company nor any of its
Subsidiaries nor any of their respective properties is or are
subject to any Order affecting or involving the Consumables
Business, the Process Business or the Transferred Assets, except
for those that, individually or in the aggregate, would not
reasonably be expected to interfere in any material respect with
the conduct of the Consumables Business or the Transferred Process
Operations as currently conducted or the use of the Transferred
Assets. There are no formal or informal SEC inquiries or
investigations, other governmental inquiries or investigations or
internal investigations or material whistle-blower complaints
pending, or to the Knowledge of the Company with respect to SEC or
other governmental inquiries or investigations, threatened,
relating to, affecting or involving the Consumables Business, the
Process Business or the Transferred Assets, including the
Transferred Subsidiaries.
(m) Licenses and Permits;
Compliance with Laws . Except (other than in the case of
clauses (i) and (ii) below) as, individually or in the aggregate,
has not had, and would not reasonably be expected to have, a
Material Adverse Effect:
(i) the Company or the
Transferred Subsidiaries owns or possess all material Licenses and
Permits, and have made all filings, applications and registrations
with all Governmental Authorities (including all authorizations
required by the Drug
29
Enforcement Administration
and under the Federal Food, Drug and Cosmetic Act, the regulations
of the United States Food and Drug Administration and Environmental
Laws and all other similar Laws in other applicable jurisdictions)
and all such Licenses and Permits are in full force and
effect;
(ii) no loss of any such
material Licenses and Permits is pending in any Proceeding or, to
the Knowledge of the Company, has been threatened by a Governmental
Authority, except for normal expirations in accordance with the
terms thereof or applicable Law and all such Licenses and Permits
may be transferred to the Buyer or its Subsidiaries;
(iii) the Company and each of
the Transferred Subsidiaries have complied with (A) all terms and
conditions of all Licenses and Permits and (B) all Laws applicable
to the operation of each of the Consumables Business and the
Process Business and ownership or use of the Transferred Assets,
and it has not received any written notice of any pending
Proceeding alleging facts which, if true, would constitute a
failure to comply with either (A) or (B) of this Section
4.1(m)(iii) ;
(iv) there are no (A)
unresolved violations, criticisms or exceptions noted by any
Governmental Authority in any report, comment letter or other
written statement relating to or based on any examinations of the
Consumables Business, the Process Business, the Transferred
Subsidiaries or, with respect to the Consumables Business, the
Process Business and the Transferred Assets, the Company or its
Subsidiaries or (B) written agreements, memoranda of understanding,
commitment letters or similar undertakings to which the Consumables
Business, the Process Business, the Transferred Subsidiaries or,
with respect to the Consumables Business, the Process Business and
the Transferred Assets, the Company or its Subsidiaries is a party,
or Orders from, or any resolution adopted at the request of, any
Governmental Authority; and
(v) to the Knowledge of the
Company, each third party at any time engaged in the testing,
manufacturing, storage, packaging, labeling, sale or distribution
of a product on behalf of the Consumables Business, the Process
Business, the Transferred Subsidiaries or, with respect to the
Consumables Business, the Process Business and the Transferred
Assets, the Company or its Subsidiaries has been, in compliance
with all applicable Laws and Licenses and Permits which have
jurisdiction over the products being tested, manufactured, stored,
packaged, labeled, sold or distributed on behalf of the Consumables
Business, the Process Business, the Transferred Subsidiaries or,
with respect to the Consumables Business, the Process Business and
the Transferred Assets, the Company or its Subsidiaries;
provided , that with respect to this Section
4.1(m)(v) , the term “Knowledge of the Company”
shall mean, with respect to any such matter, the actual knowledge,
without due inquiry, of the individuals listed in Section
1.1(i) of the Company Disclosure Schedule.
(n) Environmental
Matters . Except as, individually or in the aggregate, has not
had, and would not reasonably be expected to have, a Material
Adverse Effect:
(i) The Company, its
Subsidiaries, the Consumables Business and the Process Business
have complied with all Environmental Laws and, to the Knowledge
of
30
the Company, there is no
condition that would, individually or in the aggregate, reasonably
be expected to prevent or interfere with compliance with all
Environmental Laws (in effect on the date hereof) in the
future;
(ii) the Transferred Real
Property and all property operated by the Company or any of its
Subsidiaries or otherwise owned, used, occupied or operated in
connection with the Consumables Business or the Process Business
(including soils, groundwater, surface water, buildings, equipment
or other structures or facilities) do not contain and are not
contaminated with any Hazardous Substance and no foreseen or
proposed alterations or improvements are required within three (3)
years from the date hereof in relation to such properties in order
to maintain compliance with Environmental Laws;
(iii) the properties formerly
owned or operated by the Company or any of its Subsidiaries or
otherwise owned or operated in connection with the Consumables
Business or the Process Business were not contaminated with any
Hazardous Substance during the period of ownership or operation by
the Company or any of its Subsidiaries;
(iv) neither the Company nor
any of its Subsidiaries is subject to liability for any Hazardous
Substance disposal or contamination on any third party property
under Environmental Laws;
(v) neither the Company nor
any of its Subsidiaries has received any notice, demand, letter,
claim or request for information indicating that the Company, any
of its Subsidiaries, the Consumables Business or the Process
Business may be in violation of or subject to liability under any
Environmental law;
(vi) neither the Company nor
any of its Subsidiaries is subject or a party to any indemnity or
other agreement with any third party relating to any Environmental
Law or Hazardous Substances; and
(vii) there are no other
circumstances or conditions involving the Company, any of its
Subsidiaries, the Consumables Business or the Process Business that
could be reasonably likely to result in any claims, liability,
investigations, costs or restrictions on the ownership, use or
transfer of any property of the Company or any of its Subsidiaries
used or held for use in the conduct or operation of the Acquired
Businesses pursuant to any Environmental Law.
(o) Employee Benefit
Plans .
(i) Section 4.1(o)(i)
of the Company Disclosure Schedule contains a true and complete
list of each “employee benefit plan” (within the
meaning of Section 3(3) of ERISA), including “multiemployer
plans” within the meaning of Section 3(37) of ERISA), and all
stock purchase, stock option, severance, employment, consulting,
independent contractor, change-in-control, fringe benefit,
collective bargaining, bonus, incentive, deferred compensation,
pensions, employee loan and all other employee benefit plans,
agreements, programs, policies or other arrangements, whether or
not subject to ERISA (including any funding mechanism therefor now
in
31
effect or required in the
future as a result of the transaction contemplated by this
Agreement or otherwise), under which (A) any Consumables Business
Employee or Process Business Employee has any present or future
right to benefits and which are contributed to, sponsored by or
maintained by the Company or its Affiliates or (B) any of the
Transferred Subsidiaries has had or has any present or future
liability. All such plans, agreements, programs, policies and
arrangements shall be collectively referred to as the “
Company Plans ”.
(ii) With respect to each
Company Plan, the Company has provided or made available to the
Buyer with a current, accurate and complete copy (or, to the extent
no such copy exists, an accurate description) thereof and, to the
extent applicable: (A) any related trust agreement or other funding
instrument, (B) the most recent determination letter, if
applicable, (C) any summary plan description and other written
communications (or a description of any oral communications) by the
Company or its Affiliates to the Consumables Business Employees or
Process Business Employee concerning the extent of the benefits
provided under a Company Plan, and (D) to the extent applicable,
for the most recent year, audited financial statements and
actuarial valuation reports.
(iii) (A) no event has
occurred and no condition exists that would subject the Company or
its Subsidiaries, either directly or by reason of their affiliation
with any member of their “Controlled Group” (defined as
any organization which is a member of a controlled group of
organizations within the meaning of Sections 414(b), (c), (m) or
(o) of the Code), to any tax, fine, lien, penalty or other
liability imposed by ERISA, the Code or other applicable Laws for
which any of the Transferred Subsidiaries, Buyer or any Designated
Purchaser would reasonably be expected to be liable, and (B) no
Company Plan is subject to Title IV of ERISA.
(iv) With respect to any
Company Plan, no administrative investigation, audit or other
administrative proceeding by the Department of Labor, the Internal
Revenue Service, Inland Revenue or other Governmental Authority are
pending, threatened or in progress which, in any such case,
individually or in the aggregate, could reasonably be expected to
result in a material liability to any of the Transferred
Subsidiaries, Buyer or any Designated Purchaser.
(v) No Company Plan exists
that, as a result of the execution of this Agreement, the
Stockholder Approval, or the transactions contemplated by this
Agreement (whether alone or in connection with any subsequent
event(s)), could: (A) result in any bonus payment, any severance
pay or any increase in severance pay upon any termination of
employment after the date of this Agreement, (B) accelerate the
time of payment or vesting or result in any payment or funding
(through a grantor trust or otherwise) of compensation or benefits
under, increase the amount payable or result in any other material
obligation pursuant to, any of the Company Plans, or (C) limit or
restrict the right of any of the Transferred Subsidiaries or Buyer
to merge, amend or terminate any of the Company Plans.
(vi) No Company Plan is
maintained outside the jurisdiction of the United States, or covers
any employee residing or working outside the United States
(any
32
such Company Plan, a “
Foreign Benefit Plan ”). With respect to any Foreign
Benefit Plans, (A) all Foreign Benefit Plans have been established,
maintained and administered in compliance in all material respects
with their terms and all applicable statutes, laws, ordinances,
rules, orders, decrees, judgments, writs, and regulations of any
controlling Governmental Authority, (B) all Foreign Benefit Plans
that are required to be funded are fully funded, and with respect
to all other Foreign Benefit Plans, adequate reserves therefore
have been established on the Closing Statement, and (C) no material
liability or obligation of the Company or its Subsidiaries exists
with respect to such Foreign Benefit Plans that has not been
disclosed on Section 4.1(o)(vi) of the Company Disclosure
Schedule.
(vii) Other than the Group
Personal Pension Plan administered by Standard Life, no agreement
or arrangement exists for the provision by the Transferred
Subsidiaries of any relevant benefits (as defined in section 612(1)
of the Income and Corporation Taxes Act 1988 of the United Kingdom
Parliament, with the omission of the exception in that definition)
for any officer or employee or former officer or employee of the
Consumables Business or for Process Business Employee or any
dependant of any of such persons and the Transferred Subsidiaries
have never participated in any agreement or arrangements providing
such relevant benefits (as defined above).
(p) Labor Matters
.
(i) Neither the Company nor
any of its Subsidiaries is a party to any U.S. or non-U.S.
collective bargaining agreement or other labor union contract (or
is subject to any statutory scheme of similar import) applicable to
all or any of the Consumables Business Employees or Process
Business Employees, nor, to the Knowledge of the Company, are there
any activities or proceedings of any labor union to organize any
Consumables Business Employees or Process Business
Employees.
(ii) The Company and its
Subsidiaries are, with respec
|